Crinetics Pharmaceuticals (CRNX) Insider Trading & Ownership $53.14 +0.37 (+0.70%) (As of 10/4/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Crinetics Pharmaceuticals (NASDAQ:CRNX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.00%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)9Amount OfInsider Selling(Last 12 Months)$32.07 M Get CRNX Insider Trade Alerts Want to know when executives and insiders are buying or selling Crinetics Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CRNX Insider Buying and Selling by Quarter Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. Crinetics Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/26/2024Marc WilsonCFOSell25,000$51.11$1,277,750.00 9/25/2024Josh GottheimerU.S. Congress Member (D-NJ)Buy$50.45$1,001 - $15,0009/10/2024Stephen F BetzInsiderSell1,035$51.50$53,302.50 8/26/2024Stephen F BetzInsiderSell3,000$53.19$159,570.00 7/25/2024Marc WilsonCFOSell19,056$53.88$1,026,737.28 7/25/2024Stephen F BetzInsiderSell3,000$53.43$160,290.00 7/15/2024Jeff E KnightCOOSell27,000$55.00$1,485,000.00 Time to pull back the curtain for you (Ad)Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the weekwatch this FREE briefing with me and expert trader Graham Lindman7/15/2024Marc WilsonCFOSell25,000$55.00$1,375,000.00 7/10/2024Stephen F BetzInsiderSell3,000$48.55$145,650.00 7/5/2024James HassardInsiderSell15,000$44.08$661,200.00 7/3/2024Dana PizzutiInsiderSell14,375$44.87$645,006.25 6/28/2024Marc WilsonCFOSell32,129$43.61$1,401,145.69 6/26/2024Jeff E KnightCOOSell956$44.38$42,427.28 6/24/2024Dana PizzutiInsiderSell9,500$45.73$434,435.00 6/21/2024James HassardInsiderSell15,000$44.66$669,900.00 6/10/2024Stephen F BetzInsiderSell3,000$43.86$131,580.00 5/28/2024Stephen F BetzInsiderSell3,000$47.49$142,470.00 5/10/2024Stephen F BetzInsiderSell3,000$49.43$148,290.00 5/8/2024Richard Scott StruthersCEOSell107,448$49.40$5,307,931.20 4/15/2024Dana PizzutiInsiderSell14,375$44.47$639,256.25 4/4/2024Richard Scott StruthersCEOSell40,951$49.17$2,013,560.67 3/28/2024Stephanie OkeyDirectorSell17,500$46.38$811,650.00 3/22/2024Jeff E KnightCOOSell32,359$44.31$1,433,827.29 3/20/2024Dana PizzutiInsiderSell15,089$44.06$664,821.34 3/20/2024Matthew K FustDirectorSell60,000$44.14$2,648,400.00 3/19/2024Marc WilsonCFOSell6,942$42.91$297,881.22 1/25/2024Stephen F BetzInsiderSell3,000$37.26$111,780.00 1/10/2024Stephen F BetzInsiderSell3,000$37.65$112,950.00 1/3/2024Dana PizzutiInsiderSell14,375$35.00$503,125.00 1/2/2024Marc WilsonCFOSell10,000$35.47$354,700.00 12/26/2023Stephen F BetzInsiderSell3,000$35.89$107,670.00 12/21/2023Dana PizzutiInsiderSell9,583$34.57$331,284.31 12/11/2023Stephen F BetzInsiderSell3,000$32.87$98,610.00 11/27/2023Stephen F BetzInsiderSell3,000$31.84$95,520.00 11/3/2023Richard Scott StruthersCEOSell199,082$30.56$6,083,945.92 11/1/2023Marc WilsonCFOSell10,000$28.75$287,500.00 10/17/2023Alan Seth KrasnerInsiderSell7,000$30.00$210,000.00 (Data available from 1/1/2013 forward) CRNX Insider Trading Activity - Frequently Asked Questions Who is on Crinetics Pharmaceuticals's Insider Roster? The list of insiders at Crinetics Pharmaceuticals includes Ajay Madan, Alan Seth Krasner, Coelho Rogerio Vivaldi, Dana Pizzuti, James Hassard, Jeff E Knight, Marc Wilson, Matthew K Fust, Perceptive Advisors Llc, Richard Scott Struthers, Stephanie Okey, and Stephen F Betz. Learn more on insiders at CRNX. What percentage of Crinetics Pharmaceuticals stock is owned by insiders? 6.00% of Crinetics Pharmaceuticals stock is owned by insiders. Learn more on CRNX's insider holdings. Which Crinetics Pharmaceuticals insiders have been buying company stock? The following insider purchased CRNX shares in the last 24 months: Coelho Rogerio Vivaldi ($110,300.00). How much insider buying is happening at Crinetics Pharmaceuticals? Insiders have purchased a total of 5,000 CRNX shares in the last 24 months for a total of $110,300.00 bought. Which Crinetics Pharmaceuticals insiders have been selling company stock? The following insiders have sold CRNX shares in the last 24 months: Alan Seth Krasner ($210,000.00), Dana Pizzuti ($3,350,551.95), James Hassard ($1,331,100.00), Jeff E Knight ($2,961,254.57), Marc Wilson ($6,638,226.53), Matthew K Fust ($2,648,400.00), Richard Scott Struthers ($15,225,126.50), Stephanie Okey ($811,650.00), and Stephen F Betz ($1,919,316.56). How much insider selling is happening at Crinetics Pharmaceuticals? Insiders have sold a total of 913,396 Crinetics Pharmaceuticals shares in the last 24 months for a total of $35,095,626.11 sold. Which members of congress are trading Crinetics Pharmaceuticals? Josh Gottheimer (D-NJ) has bought shares of Crinetics Pharmaceuticals in the last year totaling $8,000. More Insider Trading Tools from MarketBeat Related Companies: Ionis Pharmaceuticals Insider Trading Avadel Pharmaceuticals Insider Trading Bicycle Therapeutics Insider Trading Viatris Insider Trading Vaxcyte Insider Trading Sarepta Therapeutics Insider Trading Catalent Insider Trading Roivant Sciences Insider Trading Intra-Cellular Therapies Insider Trading Lantheus Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insiders Are Betting Big on These 2 StocksThis Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are Buying This page (NASDAQ:CRNX) was last updated on 10/6/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredHow much money are you leaving on the table from the stocks you already own?Charles Payne here, and I want to let you in on a time-tested trading method that can be used to generate cash...Unstoppable Prosperity | SponsoredAI Expert Reveals New PickEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredGolden Equation: Volatility = OpportunityWhen the market swings wildly, most investors panic… But it doesn't have to be this way. You see, when t...Prosper Trading Academy | SponsoredNext opportunity for crypto millionsAll the Pieces Falling into Place for Crypto… Unlock the Potential of the 2024 Crypto Bull Run!Crypto 101 Media | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Crinetics Pharmaceuticals, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Crinetics Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.